HER2 targeted therapy is a newly developed method to treat HER2 positive tumors in recent years, such as breast cancer (Hackshaw et al., 2020), gastric cancer, and esophageal cancer (Gerson et al., 2017), with obvious effects. This evidence concerns the gene ERBB2 and breast carcinoma.